Introduction: Transcatheter-Arterial embolization (TAE) is an established regional, palliative treatment option for liver metastases in patients (pts) with neuroendocrine neoplasms (NENs).
Aim(s): To assess the safety/efficacy of TAE and identify predictors of treatment outcomes in NEN pts.
Materials and methods: A single-institution retrospective analysis reviewed 74 patients with histologically proven NENs. Symptoms’ scores, biomarkers [Chromogranin-A (CGA), 5-Hydroxyindolacetic acid (5-HIAA)], cross-sectional imaging, previous treatments were assessed. Symptoms’ progression was defined as 50% increase of symptoms’ score. Radiological progression was based on RECIST.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Medical treatment - Targeted therapies
Presenting Author: Dr Eleni Armeni
, Armeni E
, Sullivan L
, Aristidou I
, Gopaul A
, Gertner J
, Yu D
, Von Stempel C
, Davies N
, Mandair D
, Caplin M
, Toumpanakis C
To read results and conclusion, please login ...
Further abstracts you may be interested in